Human placental alkaline phosphatase (hPLAP) is the most frequently elevated serum marker in testicular cancer;Die humane plazentare alkalische Phosphatase (hPLAP) ist der am häufigsten erhöhte Serummarker beim Hodentumor

Aktuelle Urologie

Volumn 42, Issue 5, 2011, Pages 311-315

  Neumann, A ^a   Keller, T ^b   Jocham, D ^a   Doehn, C ^a,c  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b ACOMED Statistik   (Germany)

^c Urologikum Lübeck ^*  (Germany)

Author keywords

hPLAP; non seminoma; seminoma; testicular cancer; tumour marker

Indexed keywords

AFP PROTEIN, HUMAN; ALKALINE PHOSPHATASE; ALKALINE PHOSPHATASE, PLACENTAL; ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; ISOENZYME; LACTATE DEHYDROGENASE; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; CANCER STAGING; HUMAN; MALE; MIDDLE AGED; NEOPLASM; NONSEMINOMATOUS GERM CELL TUMOR; PATHOLOGY; PREDICTIVE VALUE; REFERENCE VALUE; RETROSPECTIVE STUDY; SEMINOMA; TESTIS DISEASE; TESTIS TUMOR;

ADOLESCENT; ADULT; AGED; ALKALINE PHOSPHATASE; ALPHA-FETOPROTEINS; CHORIONIC GONADOTROPIN; GPI-LINKED PROTEINS; HUMANS; ISOENZYMES; L-LACTATE DEHYDROGENASE; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, GERM CELL AND EMBRYONAL; PREDICTIVE VALUE OF TESTS; REFERENCE VALUES; RETROSPECTIVE STUDIES; SEMINOMA; TESTICULAR DISEASES; TESTICULAR NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 80052587307     PISSN: 00017868     EISSN: 14388820     Source Type: Journal    
DOI: 10.1055/s-0031-1271545     Document Type: Article

References (16)

1. Robert Koch-Institut. http://www.rki.de (aufgerufen am 27.12.2010)
2. Krege S, Beyer J, Souchon R et al. European consensus on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): partI. Eur Urol 2008 53 478-496
3. International Germ Cell Cancer Collaborative Group. International germ cell cancer consensus classification: a prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol 1997 15 594-603
4. Weibach L, Bussar-Maatz R, Mann K. The value of tumor markers in testicular seminomas. Results of a prospective multicenter study. Eur Urol 1997 32 16-22 (Pubitemid 27363871)
5. Souchon R, Schmoll H J., Krege S. Leitlinie zur Diagnostik und Therapie von Hodentumoren auf Grundlage evidenzbasierter Medizin (EBM). 1. Auflage München W. Zuckerschwerdt 2002
6. Sachs L, Hedderich J. Angewandte Statistik: Methodensammlung mit R. 13. Auflage Berlin Springer 2009
7. Hanley J A., McNeil B J. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983 149 838-843
8. Fishman L, Miyayama H, Driscoll S G. et al. Developmental phase-specific alkaline phosphatase isoenzymes of human placenta and their occurrence in human cancer. Cancer Res 1976 36 2268-2273
9. Lamerz R, Albrecht W, Bialk P et al. Tumour markers in germ cell cancer:EGTM Recommendations. Anticancer Research 1999 19 2785-2820
10. Stinghen S T., Moura J F., Zancanella P et al. Specific immunoassays for placental alkaline phosphatase as a tumor marker. J Biomed Biotechnol 2006 1-8
11. Nielsen O S., Munro A J., Duncon W et al. Is placental alkaline phosphatase (PLAP) a useful marker for seminoma? Eur J Cancer 1990 26 1049-1054
12. Albrecht W, De Santis M, Dossenbach-Glaninger A. Testicular tumor markers: Corner-stones in the managment of malignant germ cell tumors. J Lab Med 2004 28 109-115 (Pubitemid 38648095)
13. Sturgeon C M., Duffy M J., Stenman U H. et al. National Academy of Clinical Biochemistry. National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers. Clin Chem 2008 54 e11-e79 (Pubitemid 352777353)
14. Stenman U H., Lamerz R, Looijenga L H., (NACB sub-committee members Testicular Cancer). National Academy of clinical biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast and ovarian cancers. Clin Chem 2008 54 11-79
15. National Comprehensive Cancer Network. http://www.nccn.org (aufgerufen am 27.12.2010)
16. Gilligan T D., Seidenfeld J, Basch E M., et al., American Society of Clinical Oncology. American Society of Clinical Oncology Clinical Practice Guideline on uses of serum tumor markers in adult males with germ cell tumors. J Clin Oncol 2010 28 3388-3404